← Browse by Condition
Medical Condition
diabetic retinopathy
Total Trials
9
Recruiting Now
9
Trial Phases
Phase 1, Phase 2, Phase 2, Phase 3
ClinicalMetric tracks all active clinical trials for diabetic retinopathy sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — diabetic retinopathy Clinical Trials
How many clinical trials are currently recruiting for diabetic retinopathy?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for diabetic retinopathy, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for diabetic retinopathy?
diabetic retinopathy research spans Phase 1 (1 trial), Phase 2 (2 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a diabetic retinopathy clinical trial?
Eligibility criteria for diabetic retinopathy trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Phase 2 2
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07002372
Recruiting
Enrollment
182 pts
Location
China
Sponsor
Second Affiliated Hospital, Sc...
NCT03403686
Recruiting
Enrollment
104 pts
Location
United States
Sponsor
University of Alabama at Birmi...
NCT05147701 Phase 1
Recruiting
Enrollment
20 pts
Location
Antigua and Barbuda,...
Sponsor
The Foundation for Orthopaedic...
NCT07151001
Recruiting
Enrollment
922 pts
Location
United States
Sponsor
iHealthScreen Inc
NCT06782997
Recruiting
Enrollment
270 pts
Location
France
Sponsor
CHU de Reims
NCT06770933 Phase 2
Recruiting
Enrollment
100 pts
Location
United States, Austr...
Sponsor
Vantage Biosciences Ltd
NCT06582472
Recruiting
Enrollment
180 pts
Location
Italy
Sponsor
IRCCS Ospedale San Raffaele
NCT07592273 Phase 2, Phase 3
Recruiting
Enrollment
576 pts
Location
United States, Puert...
Sponsor
AbbVie
NCT04240652
Recruiting
Enrollment
500,000 pts
Location
China
Sponsor
Shanghai Jiao Tong University ...
Related Conditions
age related macular degeneration (1) choroidal neovascularization (1) retinal vein occlusion (1) cystoid macular edema (1) eye diseases (1) retinitis pigmentosa (1) macular degeneration (1) traumatic optic neuropathy (1) optic atrophy (1) diabetes (1) npdr non proliferative diabetic retinopathy (1) diabetic retinopathy associated with type 2 diabetes mellitus (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology